Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07135799cc0bb655891b8fa5b170b6f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0817b3c31c2e731d74619a2921c0a57b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab954b5e93d5819291dfe01294f22719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d339290b12515f2a2054d9c4019172c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4e08a13befa3bdca20993ae9acf94d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16 |
filingDate |
2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c60e0ed43a0e53c9103034e123c45d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41bb5df96b8fac5172100852ae42b5ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_940c5d70d1c842dbacb513c8cbf9f849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf6089fd31d0dd52ade33d2dc02ba0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9885a0bfdaaa6c145ec2cb8d634a93b2 |
publicationDate |
2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008161577-A1 |
titleOfInvention |
Substituted pyrrolidine and related compounds |
abstract |
This invention is directed to compounds of formula I: n n n n n n n n n n n n wherein R 1 -R 5 and a-e are as defined in the specification; or pharmaceutically-acceptable salt or solvate or stereoisomer thereof. The invention also directed to pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors using such compounds. |
priorityDate |
2003-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |